|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/55 | |
| A61K 39/395 | |||
| A61K 35/16 | |||
| A61P 25/28 |
| (11) | Number of the document | 3068424 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14802790.7 |
| Date of filing the European patent application | 2014-11-12 | |
| (97) | Date of publication of the European application | 2016-09-21 |
| (45) | Date of publication and mention of the grant of the patent | 2020-09-09 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2014/065180 |
| Date | 2014-11-12 |
| (87) | Number | WO 2015/073514 |
| Date | 2015-05-21 |
| (30) | Number | Date | Country code |
| 201361903643 P | 2013-11-13 | US |
| (72) |
BROOM, Colin, US
DAYNO, Jeffrey, US
|
| (73) |
Takeda Pharmaceutical Company Limited ,
1-1, Doshomachi 4-chome,
Chuo-ku,, Osaka-shi, Osaka,
JP
|
| (54) | COMPOSITIONS AND METHODS USEFUL FOR THE TREATMENT OF NEUROMYELITIS OPTICA SPECTRUM DISORDERS |
| COMPOSITIONS AND METHODS USEFUL FOR THE TREATMENT OF NEUROMYELITIS OPTICA SPECTRUM DISORDERS |